1.24
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tenax Therapeutics Inc | TENX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 1.24 | 0.00 | 0.00 | 0.00 | 1.24 | 08:24:50 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.25 | 1.30 | 0.05 | 3.85% | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2 | 822 | $ 1.24 | $ 1,019 | 390,063 | 0.25 - 2.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:00:01 | formt | 348 | $ 1.24 | USD |
Tenax Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 15.65M | 12.62M | 12.59M | $ - | $ - | -1.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Tenax Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TENX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.25 | 1.53 | 1.23 | 1.33 | 459,383 | -0.01 | -0.8% |
| 1 Month | 0.9352 | 1.53 | 0.90 | 1.21 | 449,468 | 0.3048 | 32.59% |
| 3 Months | 0.73 | 2.90 | 0.7063 | 1.49 | 1,446,250 | 0.51 | 69.86% |
| 6 Months | 1.26 | 2.90 | 0.25 | 1.38 | 757,815 | -0.02 | -1.59% |
| 1 Year | 1.25 | 2.90 | 0.25 | 1.37 | 407,039 | -0.01 | -0.8% |
| 3 Years | 7.96 | 12.63 | 0.25 | 3.33 | 407,930 | -6.72 | -84.42% |
| 5 Years | 71.80 | 79.60 | 0.25 | 9.07 | 369,306 | -70.56 | -98.27% |
Tenax Therapeutics Description
| Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The company develops novel product candidates such as Levosimendan that have the potential to address various critical care conditions with a high unmet medical need. Its drugs help in the reduction of morbidity and mortality in cardiac surgery patients. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. |
